Black children with eczema are more likely to develop asthma, study finds.

Published Date: 02 Mar 2023

Black children with atopic dermatitis are more likely to have asthma than non-Hispanic white children, but are less likely to be affected by an allergen.

Read Full News

Latest News

March 4: A Match Deadline Med Students Can’t Miss

The deadline is 9 PM ET Wednesday for fourth-year students to submit their residency preference lists.

Exclusive-South Carolina Seeks Non-CDC Reinforcements to Contain Growing Measles Outbreak

A dozen public health experts are arriving in South Carolina to help the state contain the largest U.S. measles outbreak in more than 30 years, but they're not coming from...

BMI Shapes Oxytocin Needs in Labor Induction

Individuals receiving maximum oxytocin doses have elevated risk for cesarean delivery and postpartum hemorrhage, but the risks are attenuated in those with elevated BMI.

Match Making Made Easy: ‘Take a Deep Breath’

Med students have until March 4 to finalize their Match lists. There is a lot to consider before then.

How These Doctors Fight the Social Media Trust War

As trust in healthcare erodes and disinformation thrives on social media, a small but determined group of physicians wants to win.

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

Todays Updates

Immunotherapy Remains Little Used in Head and Neck Cancer

Immune checkpoint inhibitors have been FDA-approved for head and neck cancer for a decade, but their use has only marginally increased among patients younger than 65.

EVP Beats Cisplatin for Resectable MIBC

As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.

Todays Updates

Immunotherapy Remains Little Used in Head and Neck Cancer

Immune checkpoint inhibitors have been FDA-approved for head and neck cancer for a decade, but their use has only marginally increased among patients younger than 65.

EVP Beats Cisplatin for Resectable MIBC

As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.

Latest News

The deadline is 9 PM ET Wednesday for fourth-year students to submit their residency preference lists.

A dozen public health experts are arriving in South Carolina to help the state contain the largest U.S. measles outbreak in more than 30 years, but they're not coming from...

Individuals receiving maximum oxytocin doses have elevated risk for cesarean delivery and postpartum hemorrhage, but the risks are attenuated in those with elevated BMI.

Med students have until March 4 to finalize their Match lists. There is a lot to consider before then.

As trust in healthcare erodes and disinformation thrives on social media, a small but determined group of physicians wants to win.

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

News All Time

Icotrokinra beneficial for adults, teens with plaque psoriasis

For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 receptor with the targeted oral peptide icotrokinra yields a significantly higher incidence of skin clearance at ...

How controlling sunburn-triggered inflammation may prevent skin cancer

Sunlight is vital for human health as it helps the body produce essential nutrients, such as vitamin D. However, too much sun exposure can significantly increase the risk of skin cancer.

Cellular protein FGD3 boosts breast cancer chemotherapy and immunotherapy, study finds

A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a ...

Gut bacterium may sabotage liver cancer immunotherapy, study suggests

A research team led by the Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified a critical factor contributing ...

Researchers try bold new approach in a race to better treat autoimmune diseases

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases—by reprogramming patients' out-of-whack immune systems.

Immune reactions found behind human rejection of transplanted pig kidneys

Researchers have uncovered and then overcome an obstacle that has led to the failure of pioneering efforts in xenotransplantation, in which an animal kidney is transplanted into a human.

Common cold virus may unlock better COVID vaccine

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill ...

Global reviews call for urgent action on endometriosis in most world regions

Two reviews published in The Lancet Obstetrics, Gynecology & Women's Health reveal stark global inequities in how endometriosis is recognized, treated, and prioritized in national health systems.

Mental and physical coaching before surgery prepares immune system and reduces complications, trial finds

The weeks leading up to a major surgery can be a time of uncertainty and worry for patients, many of whom anticipate the need for rehabilitation to get back on their feet. But if patients improve their physical and mental ...

Rapid growth of radiopharmaceutical therapy highlights need for expertise

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining the education, training, and experience needed to ensure the safe and effective delivery of radiopharmaceutical therapy ...

Flu vaccine performance varies by age, study reveals

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age ...

Study tracking how tumor microenvironment develops signals opportunity for early detection, risk prediction

Colorectal cancer precursor lesions are benign growths that can develop into colorectal cancer (CRC) over time, through either a conventional or serrated pathway. Understanding how the immune system reacts to these precursor ...

Researchers aim to disrupt breast cancer line of communication and prevent spread

Cancer Center at Illinois (CCIL) Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer progression with crucial implications for breast cancer therapeutics.

Study reveals why some myeloma patients stay cancer-free for years after CAR T therapy

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell therapy, while others see ...

T cell therapies show long-term HPV gains

Researchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer Center, and RWJBarnabas Health, along with colleagues from the National Cancer Institute, a center ...

FDA grants fast track designation to drug combo for colorectal cancer

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by the University of Oklahoma ...

Recommended News For You

Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?

Alcohol Causes Cancer. We Should Be Drinking Less.

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance

According to new studies, some cancer patients can safely forego radiation therapy.

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.

Recommended Articles For You

A Visual Journey Through Penile Cancer: Examining the Impact of Photos 

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies  

Hemophilia: Pathophysiology, Genetics, and Treatment Advances 

Exploring the Mysteries of Myxoma: A New Frontier in Medical Research 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

2.

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

3.

Living in a more pedestrian-friendly area may reduce the risk of cancer and obesity-related diseases.

4.

An Eye Surgeon's Unexpected Discovery of the "Before and After".

5.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

1.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

2.

Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management

3.

Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds

4.

Uncovering the Mystery of Burkitt's Lymphoma: A New Hope for Treatment

5.

Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

4.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

5.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot